US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

McKesson Corporation

us-stock
To Invest in {{usstockname}}
us-stock
$805.37 -0.0293(-2.93%) MCK at 04 Dec 2025 04:38 PM Medical Distribution
Lowest Today 802.75
Highest Today 835.39
Today’s Open 835.39
Prev. Close 829.7
52 Week High 894.75
52 Week Low 555.78
Day’s Range: Low 802.75 High 835.39
52-Week Range: Low 555.78 High 894.75
1 day return -
1 Week return -8.63
1 month return -4.43
3 month return +16.43
6 month return +13.34
1 year return +31.62
3 year return +110.51
5 year return +345.2
10 year return -

Institutional Holdings

Vanguard Group Inc 9.71

BlackRock Inc 9.05

State Street Corp 4.58

JPMorgan Chase & Co 3.87

Massachusetts Financial Services Company 3.20

Vanguard Total Stock Mkt Idx Inv 3.16

Vanguard 500 Index Investor 2.49

Geode Capital Management, LLC 2.27

Franklin Resources Inc 2.08

Morgan Stanley - Brokerage Accounts 1.94

MFS Large Cap Value Equity 1.89

MFS Value A 1.88

AllianceBernstein L.P. 1.82

FMR Inc 1.73

NORGES BANK 1.48

T. Rowe Price Investment Management,Inc. 1.44

Bank of America Corp 1.38

Fidelity 500 Index 1.28

Northern Trust Corp 1.23

SPDR® S&P 500® ETF 1.21

iShares Core S&P 500 ETF 1.21

Royal Bank of Canada 1.21

UBS Asset Mgmt Americas Inc 1.04

JPMorgan Large Cap Growth I 1.01

Boston Partners Global Investors, Inc 1.00

Arrowstreet Capital Limited Partnership 0.99

Putnam Large Cap Value A 0.92

Putnam US Large Cap Value Equity 0.92

T. Rowe Price Capital Appreciation 0.91

Vanguard Value Index Inv 0.89

Nordea Investment Mgmt Bank Demark A/s 0.80

WCM Investment Management 0.79

Loomis Sayles Core 0.78

Loomis Sayles Core Fixed Income Trust B 0.78

The Health Care Select Sector SPDR® ETF 0.69

AllianceBernstein US L/C Growth Eqty MF 0.65

Vanguard Institutional Index I 0.61

Vanguard Dividend Appreciation ETF 0.55

State St S&P 500® Indx SL Cl III 0.54

Loomis Sayles Intermediate Duration FI 0.42

Market Status

Strong Buy: 10

Buy: 3

Hold: 3

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 103201.73 M

PB Ratio 5.0435

PE Ratio 26.8078

Enterprise Value 111551.06 M

Total Assets 75140.00 M

Volume 1486054

Company Financials

Annual Revenue FY25:359051000000 359051.0M, FY24:308951000000 308951.0M, FY23:276711000000 276711.0M, FY22:263966000000 263966.0M, FY21:238228000000 238228.0M

Annual Profit FY25:12485000000 12485.0M, FY24:12584000000 12584.0M, FY23:12358000000 12358.0M, FY22:13130000000 13130.0M, FY21:12148000000 12148.0M

Annual Net worth FY25:3295000000 3295.0M, FY24:3002000000 3002.0M, FY23:3560000000 3560.0M, FY22:1114000000 1114.0M, FY21:-4339000000 -4339.0M

Quarterly Revenue Q3/2025:103150000000 103150.0M, Q2/2025:97827000000 97827.0M, Q1/2025:90823000000 90823.0M, Q4/2024:95294000000 95294.0M, Q3/2024:93651000000 93651.0M

Quarterly Profit Q3/2025:3542000000 3542.0M, Q2/2025:3279000000 3279.0M, Q1/2025:2920000000 2920.0M, Q4/2024:3284000000 3284.0M, Q3/2024:3248000000 3248.0M

Quarterly Net worth Q3/2025:1110000000 1110.0M, Q2/2025:784000000 784.0M, Q1/2025:1260000000 1260.0M, Q4/2024:879000000 879.0M, Q3/2024:241000000 241.0M

Fund house & investment objective

Company Information McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Organisation Medical Distribution

Employees 43000

Industry Medical Distribution

CEO Mr. Brian S. Tyler Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right